Siemens Healthineers Appoints John Kowal President and Head of the AmericasCurrent President Dave Pacitti to become chief executive officer of Avanos

John Kowal, president of the Americas for Varian, is appointed president and head of the Americas for Siemens Healthineers, effective April 14, 2025. He succeeds David Pacitti, who has accepted the role of chief executive officer of Avanos (NYSE: AVNS), also effective April 14, 2025. 

"We are very thankful for Dave's commitment over the last decade to position Siemens Healthineers as a leading medtech company in the United States," said Darleen Caron, CHRO and member of the Managing Board at Siemens Healthineers with responsibility for The Americas. "We are particularly grateful for his leadership in building strategic Value Partnerships with world-renowned medical institutions in the U.S."

Caron added: "We are very pleased to appoint John Kowal as our new president and head of the Americas. His track record of cultivating long-term, deep customer relationships has significantly contributed to our leading market position in the Varian business segment. His outstanding commercial and overall leadership capabilities make John the ideal candidate for this role."

John Kowal joined the Varian sales team in 2005. From 2010 onward, he held several management positions of increasing scope and complexity and in 2017 he took on the role of president of the Americas for Varian.

John holds a Bachelor of Science degree in mechanical engineering from Worcester Polytechnic Institute and graduated from the executive development program of The Wharton School at the University of Pennsylvania.

Julie Gibson
Phone: +1 917 929 5779
Email: julie.gibson@siemens-healthineers.com

Visit the Siemens Healthineers Press Center.

Siemens Healthineers pioneers breakthroughs in healthcare. For everyone. Everywhere. Sustainably. The company is a global provider of healthcare equipment, solutions and services, with activities in more than 180 countries and direct representation in more than 70. The group comprises Siemens Healthineers AG, listed as SHL in Frankfurt, Germany, and its subsidiaries. As a leading medical technology company, Siemens Healthineers is committed to improving access to healthcare for underserved communities worldwide and is striving to overcome the most threatening diseases. The company is principally active in the areas of imaging, diagnostics, cancer care and minimally invasive therapies, augmented by digital technology and artificial intelligence. In fiscal 2024, which ended on September 30, 2024, Siemens Healthineers had approximately 72,000 employees worldwide and generated revenue of around €22.4 billion. Further information is available at www.siemens-healthineers.com.